TRIDENT Preclinical Trials
Research Services • 
London, Ontario, Canada • 1-10 Employees
Company overview
| Headquarters | 1151 Richmond St, London, Ontario N6A 3K7, CA |
| Website | |
| NAICS | 5417 |
| Founded | 2023 |
| Employees | 1-10 |
| Socials |
Key Contact at TRIDENT Preclinical Trials
Sriram Jayabal
Research Program Director
About TRIDENT Preclinical Trials
The TRanslational Initiative to DE-risk NeuroTherapeutics (TRIDENT) is revolutionizing preclinical trials for the treatments of neurodegenerative diseases with a $24M grant from the Government of Canada's New Frontiers In Research program. TRIDENT leverages innovative cognition testing, advanced molecular and imaging techniques, and existing industry and academic partnerships to identify and predict highly successful drug candidates. By transforming the nature of preclinical evaluation, our platform will radically improve our ability to identify disease-modifying therapies leading to a world without brain disease.
TRIDENT Preclinical Trials revenue & valuation
| Annual revenue | $427,775 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Research Services industry and current estimated revenues | $1,400,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Funding Data
TRIDENT Preclinical Trials has never raised funding before.
TRIDENT Preclinical Trials Tech Stack
Discover the technologies and tools that power TRIDENT Preclinical Trials's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
Issue trackers
Appointment scheduling
Blogs
Miscellaneous
Security
Miscellaneous
JavaScript frameworks
IaaS
CDN
Performance
Ecommerce
United Kingdom
United States
France
Sweden
Frequently asked questions
4.8
40,000 users
